These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33020154)

  • 21. Modification of Vancomycin Dosing in Cardiac Surgery With Cardiopulmonary Bypass.
    Wang L; Yu XB; Zhou ZY; Wang J; Zheng LP; Dai Y; Wang YZ; Zhang XS; Chen C; Shi DW; Zhang CH
    J Clin Pharmacol; 2023 Apr; 63(4):490-497. PubMed ID: 36458612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic characteristics and microbiologic appropriateness of cefazolin for perioperative antibiotic prophylaxis in elective cardiac surgery.
    Lanckohr C; Horn D; Voeller S; Hempel G; Fobker M; Welp H; Koeck R; Ellger B
    J Thorac Cardiovasc Surg; 2016 Aug; 152(2):603-10. PubMed ID: 27209020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosing antibiotic prophylaxis during cardiopulmonary bypass-a higher level of complexity? A structured review.
    Paruk F; Sime FB; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2017 Apr; 49(4):395-402. PubMed ID: 28254373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic availability of prophylactic cefuroxime in patients submitted to coronary artery bypass grafting with cardiopulmonary bypass.
    Nascimento JW; Carmona MJ; Strabelli TM; Auler JO; Santos SR
    J Hosp Infect; 2005 Apr; 59(4):299-303. PubMed ID: 15749317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are children undergoing cardiac surgery receiving antibiotics at subtherapeutic levels?
    Huang JH; Sunstrom R; Munar MY; Cherala G; Legg A; Olyeai AJ; Langley SM
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1591-6. PubMed ID: 24521951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A practical tranexamic acid dosing scheme based on population pharmacokinetics in children undergoing cardiac surgery.
    Grassin-Delyle S; Couturier R; Abe E; Alvarez JC; Devillier P; Urien S
    Anesthesiology; 2013 Apr; 118(4):853-62. PubMed ID: 23343649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Weight-based cefuroxime dosing provides comparable orthopedic target tissue concentrations between weight groups - a microdialysis porcine study.
    Tøstesen SK; Hanberg P; Bue M; Thillemann TM; Falstie-Jensen T; Tøttrup M; Knudsen MB; Schmedes AV; Stilling M
    APMIS; 2022 Feb; 130(2):111-118. PubMed ID: 34862642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of cefazolin antimicrobial prophylaxis during cardiac surgery with cardiopulmonary bypass.
    Calic D; Ariano RE; Arora RC; Grocott HP; Lakowski TM; Lillico R; Zelenitsky SA
    J Antimicrob Chemother; 2018 Mar; 73(3):768-771. PubMed ID: 29237016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cefazolin prophylaxis in children undergoing cardiac surgery with the use of cardiopulmonary bypass-is the dosing correct?
    Jaworski R; Dzierzanowska-Fangrat K; Czajkowska A; Maruszewski B; Kansy A
    Eur J Cardiothorac Surg; 2021 Dec; 61(1):27-33. PubMed ID: 34269390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population pharmacokinetic analysis and dosing regimen optimization of aprotinin in neonates and young infants undergoing cardiopulmonary bypass.
    Tae YM; Kwak JG; Kim BH; Jang IJ; Kim WH
    J Clin Pharmacol; 2011 Aug; 51(8):1163-76. PubMed ID: 20926755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of Prophylactic Ampicillin-Sulbactam and Dosing Optimization in Patients Undergoing Cardiovascular Surgery with Cardiopulmonary Bypass.
    Yokoyama Y; Matsumoto K; Ikawa K; Watanabe E; Yamamoto H; Imoto Y; Morikawa N; Takeda Y
    Biol Pharm Bull; 2015; 38(11):1817-21. PubMed ID: 26521833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population Pharmacokinetics of Cefuroxime in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration With Regional Citrate Anticoagulation and a Phosphate-Containing Replacement Fluid.
    Janssen PK; Foudraine NA; Burgers DM; Neef K; le Noble JL
    Ther Drug Monit; 2016 Dec; 38(6):699-705. PubMed ID: 27494946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetics of olprinone in patients undergoing cardiac surgery with cardiopulmonary bypass.
    Tsubokawa T; Ishizuka S; Fukumoto K; Ueno K; Yamamoto K
    J Anesth; 2013 Apr; 27(2):243-50. PubMed ID: 23090059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cefuroxime plasma and tissue concentrations in patients undergoing elective cardiac surgery: Continuous vs bolus application. A pilot study.
    Skhirtladze-Dworschak K; Hutschala D; Reining G; Dittrich P; Bartunek A; Dworschak M; Tschernko EM
    Br J Clin Pharmacol; 2019 Apr; 85(4):818-826. PubMed ID: 30636060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic modeling of tranexamic acid for patients undergoing cardiac surgery with normal renal function and model simulations for patients with renal impairment.
    Yang QJ; Jerath A; Bies RR; Wąsowicz M; Pang KS
    Biopharm Drug Dispos; 2015 Jul; 36(5):294-307. PubMed ID: 25704361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of Cefazolin in Patients With Obesity Undergoing Surgery Requiring Cardiopulmonary Bypass.
    Poltak J; Connors C; Wungwattana M; Nicolau D; Mercuro NJ; Liu J
    J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt B):2942-2947. PubMed ID: 35227575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of ε-Aminocaproic Acid in Neonates Undergoing Cardiac Surgery with Cardiopulmonary Bypass.
    Eaton MP; Alfieris GM; Sweeney DM; Angona RE; Cholette JM; Venuto C; Anderson B
    Anesthesiology; 2015 May; 122(5):1002-9. PubMed ID: 25723765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is single-dose antibiotic prophylaxis sufficient for coronary artery bypass surgery? An analysis of peri- and postoperative serum cefuroxime and vancomycin levels.
    Vuorisalo S; Pokela R; Syrjälä H
    J Hosp Infect; 1997 Nov; 37(3):237-47. PubMed ID: 9421775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose optimization of cefazolin in South African children undergoing cardiac surgery with cardiopulmonary bypass.
    Gebreyesus MS; Dresner A; Wiesner L; Coetzee E; Verschuuren T; Wasmann R; Denti P
    CPT Pharmacometrics Syst Pharmacol; 2024 Jul; ():. PubMed ID: 38962872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population Pharmacokinetics of Cefoxitin Administered for Pediatric Cardiac Surgery Prophylaxis.
    Ricci Z; Benegni S; Cies JJ; Marinari E; Haiberger R; Garisto C; Rizza A; Giorni C; Di Chiara L; Arpicco S; Muntoni E; Ferrari F; Milla P
    Pediatr Infect Dis J; 2020 Jul; 39(7):609-614. PubMed ID: 32221166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.